World Health Expo Miami (FIME) isn’t just an event; it’s where healthcare ideas come to life and shape the future. By bringing together healthcare innovators, exhibitors, industry leaders, buyers, and investors, it creates meaningful connections and drives real progress.

From discovering new trends to building partnerships and exploring transformative solutions, WHX Miami helps turn ideas into impact.

• Spot emerging trends in the healthcare industry
• Connect with decision-makers
• Build global partnerships
• Drive business growth

Aegis at WHX Miami: A Continuing Journey

Last year, Aegis Lifesciences participated in WHX Miami (formerly FIME), creating an engaging booth experience through product showcases, live demonstrations, and meaningful interactions with healthcare professionals from across the globe.

The images below capture moments from our previous participation, highlighting the valuable connections and experiences shared during the event.

WHX Miami continues to be an important platform for connecting with the global healthcare community and showcasing our commitment to advancing surgical care and improving patient outcomes.

Aegis Lifesciences at WHX Miami 2026

Continuing this journey, Aegis Lifesciences is proud to participate in WHX Miami 2026, taking place from June 17–19, 2026, at the Miami Beach Convention Center (Booth C29).

Aegis Lifesciences is proud to be part of this dynamic event, presenting a broad portfolio of haemostatic solutions for effective surgical care. Through our trusted solutions, we aim to support safer surgeries and better patient outcomes.

Showcasing Our Advanced Haemostatic Solutions

At WHX Miami 2026, we are proud to showcase a broad range of haemostatic solutions for both human and veterinary care, designed to support safer and more reliable surgical procedures.

Our featured solutions include:

• SURGISPON^®– Absorbable gelatin sponge and powder designed to support quick and effective haemostasis
• DENTOSPON^®– Foam gelatin with colloidal silver, designed to support haemostasis and help protect against oral microorganisms
• FLOGEL^®– Flowable gelatin haemostatic matrix for managing bleeding in tight, irregular, and difficult-to-reach surgical sites
• HAEMOVET^®– Absorbable haemostatic solutions developed to provide quick and effective haemostasis during veterinary surgeries and dental procedures
• Surgi-ORC^®– Natural, plant-based absorbable haemostat made from oxidized regenerated cellulose, designed to control capillary, venous, and minor arterial bleeding
• SURGI-PVA^™– Polyvinyl alcohol medical sponges and dressings designed for effective fluid control, including nasal packs and eye spears

All our products are developed and manufactured under an ISO 13485-certified quality management system at an FDA-registered manufacturing facility. Our operations are further supported by MDSAP certification, CE 2460 medical device compliance, MDR and CDSCO-compliant product portfolios, and a DSIR-accredited R&D facility. These globally recognized standards reflect our commitment to delivering safe, reliable, and high-quality haemostatic solutions for modern surgical care.  

Figure 1: Comprehensive Range of Haemostatic Solutions

Our participation at FIME reflects Aegis Lifesciences’ focus on advance, quality manufacturing, patient-centered care, and building strong global healthcare collaborations.

Why Should Global Distributors Visit Aegis Lifesciences at FIME?

Aegis Lifesciences is trusted by healthcare buyers and distributors worldwide for its focus on quality manufacturing, reliable supply, and long-term partnerships. At FIME, visitors can explore our broad portfolio of haemostatic solutions designed to support the evolving needs of modern surgical care.

Key advantages include:

• Global supply capability
• Gamma sterilized with SAL 10⁻⁶ assurance
• Cost-effective haemostatic solutions with up to 30% lower costs compared to the global average
• Continuous investing in R&D for innovative haemostatic product
• FDA-registered and ISO 13485-certified manufacturing facility
• Certifications from BSI Netherlands and DNV Norway
• MDSAP compliance for Australia, USA, Japan, Brazil, and Canada
• Facility certified by Globally recognized audit and MOH of various countries
• Product registrations in 80+ countries

Our team works closely with partners to provide tailored haemostatic solutions for diverse healthcare markets across the globe.

Looking Ahead to WHX Miami 2026

As healthcare continues to evolve, platforms like WHX Miami create valuable opportunities for collaboration, innovation, and knowledge sharing.

We look forward to welcoming visitors, partners, and industry professionals as we showcase our range of haemostatic solutions and connect through meaningful discussions around the future of surgical care.

At Aegis Lifesciences, we remain committed to supporting safer surgeries and better outcomes through trusted and effective solutions.

See you at WHX Miami 2026!